![Michael Watson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Michael Watson
Geen lopende functies
Loopbaan van Michael Watson
Eerdere bekende functies van Michael Watson
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Sanofi-Aventis U.S. LLC
![]() Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ. | Corporate Officer/Principal | - | - |
US Department of the Navy (District of Columbia) | Corporate Officer/Principal | 01-01-1977 | - |
Lab Pathways, Inc.
![]() Lab Pathways, Inc. Miscellaneous Commercial ServicesCommercial Services Lab Pathways, Inc. was founded in July of 2003 as a Contract Research Organization focused on in vitro toxicity screening of potential drug candidates and chemicals. CeeTox resides in 4,200-square-feet of state-of-the-art laboratory space in the Southwest Michigan Innovation Center (SMIC), a $13 million facility that serves as an incubator for new biotech companies in the Southwest Michigan area. In 2010, CeeTox purchased certain assets formerly owned by ADMETRx Inc. This asset purchase increases CeeTox's existing ADME capabilities and is yet another step in its strategy to expand its range of in vitro service offerings. The scientists at CeeTox have a collective experience of more than 100 years in areas of cell culture, biochemistry, and toxicology. The team has analyzed more than 4,000 new chemical entities and has repeatedly demonstrated the value of early in vitro toxicity data in the drug discovery process. | Verkoop & Marketing | - | - |
Opleiding van Michael Watson
The State University of New York | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 5 |
Operationeel
Corporate Officer/Principal | 2 |
Sales & Marketing | 1 |
Undergraduate Degree | 1 |
Sectoraal
Commercial Services | 2 |
Consumer Services | 2 |
Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 3 |
---|---|
Lab Pathways, Inc.
![]() Lab Pathways, Inc. Miscellaneous Commercial ServicesCommercial Services Lab Pathways, Inc. was founded in July of 2003 as a Contract Research Organization focused on in vitro toxicity screening of potential drug candidates and chemicals. CeeTox resides in 4,200-square-feet of state-of-the-art laboratory space in the Southwest Michigan Innovation Center (SMIC), a $13 million facility that serves as an incubator for new biotech companies in the Southwest Michigan area. In 2010, CeeTox purchased certain assets formerly owned by ADMETRx Inc. This asset purchase increases CeeTox's existing ADME capabilities and is yet another step in its strategy to expand its range of in vitro service offerings. The scientists at CeeTox have a collective experience of more than 100 years in areas of cell culture, biochemistry, and toxicology. The team has analyzed more than 4,000 new chemical entities and has repeatedly demonstrated the value of early in vitro toxicity data in the drug discovery process. | Commercial Services |
Sanofi-Aventis U.S. LLC
![]() Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ. | Health Technology |
US Department of the Navy (District of Columbia) | Government |
- Beurs
- Insiders
- Michael Watson
- Ervaring